Pediatric Moonshot is building an AI supercomputer for children's medicine to ensure a child's zip code doesn't determine their access to specialist care. The nonprofit deploys disease-precise AI agents across cardiology, nephrology, neurology, and oncology to bring expert-level diagnosis and treatment guidance to rural and underserved communities. Its privacy-preserving architecture keeps patient data on-site while connecting specialists, researchers, and institutions to accelerate diagnosis and improve care coordination.
Funding
Funding not disclosed
Founders
Product
Problem
Children with rare or complex conditions often face severe geographic barriers to specialist care, with 86% of rural US counties lacking a pediatric cardiologist and fewer than 500 pediatric nephrologists practicing nationwide. Families wait an average of 4.8 years for an accurate diagnosis, and critical medical information is still shared via fax, CD, or printouts, causing referrals to get lost and diagnoses to stall. This fragmentation means a child's outcome is often determined by their zip code rather than the expertise that exists elsewhere.
Solution
Pediatric Moonshot is building the world's first AI supercomputer for children's medicine, deploying disease-precise AI agents that bring specialist expertise directly to the point of care. The organization maps where diagnoses stall and referrals get lost, then connects specialists, researchers, and institutions to build tools that carry expert knowledge to any location. Their AI agents are privacy-preserving by architecture—data never moves from the hospital—and are clinically validated before touching patient pathways. The system covers four clinical focus areas where specialist access is hardest: cardiology, nephrology, neurology, and oncology, with 618 known conditions across these areas translatable into disease-precise AI agents. Pediatric Moonshot is also building next-generation patient registries and trial-precise AI agents to accelerate clinical trials for pediatric conditions.
Target Audience
Primary stakeholders are children's hospitals, rural healthcare providers, pediatric specialists, and state health leaders seeking to expand access to subspecialty care. The organization also partners with pharmaceutical companies running pediatric clinical trials and researchers working on pediatric-specific AI applications.
Features
- Disease-precise AI agents for detection and progression monitoring across cardiology, nephrology, neurology, and oncology, covering 618 known conditions
- Privacy-preserving architecture where patient data never leaves the hospital, with AI agents deployed on edge servers at children's hospitals
- Trial-precise AI agents built with pharmaceutical partners to accelerate pediatric clinical trial patient enrollment
- Next-generation patient registry infrastructure that is more representative and flexible than traditional SQL-based registries
- Four disease-precise atlases codifying the pediatric care challenge and providing the foundation for AI agent development
- Real-time streaming capability demonstrated with ultrasound transmission across continents